Shoufeng Li,
CEO
Dr. Li is a Scientist and Founder of the company. With 20 years of global pharmaceutical industry experience, he is responsible for the overall strategy, direction, and growth of the business.
Before founding Aucta, Dr. Li held management roles at Novartis Pharmaceuticals and Eon Labs (Sandoz).
Dr. Li holds a Ph.D. in Pharmaceutics and an M.S. in Statistics.
Enxian Lu,
General Manager
Dr. Lu is a Co-founder of the company. With 15 years of pharmaceutical industry experience in the areas of research, specifically related to ANDAs and NDAs, Dr. Lu is responsible for the management and operations of the business.
Prior to Aucta, he held roles of increasing responsibility at Teva and Novartis.
Dr. Lu holds a Ph.D. in Physical Pharmacy and an M.S. in Biopharmaceutics.
Hongyan Ma,
Vice President
Mr. Hongyan Ma is a Co-founder of the company. With 15 years of pharmaceutical industry experience in product development, Mr. Ma is responsible for the management and operations of the business in China.
Prior to co-founding Acuta, Mr. Ma held positions in formulation development at Sundia and Roche.
Mr. Ma holds a B.S. in Pharmaceutics.
Soby Fennell,
Vice President, Regulatory Affair
With 20 years of pharmaceutical industry experience, Ms. Fennell is responsible for company’s overall regulatory strategy and operations to support product development and commercialization.
Ms. Fennell’s experience spans regulatory, commercial, operational, and technical verticals, and she has held leadership positions at Renaissance, Teva, and Novo Nordisk.
Ms. Fennell holds a B.S. in Biochemistry.
Brian Zorn,
Pharm D, Consultant, Commercial Development
With over 26 years of pharmaceutical industry experience, including new product planning, marketing, medical communications and sales, and extensive experience in providing market/product assessments, Mr. Zorn is responsible for the commercial direction of the company.
Mr. Zorn played a key role in the launch and marketing of leading brands, including Omnicef®, Neurontin®, Lyrica® and Diovan®.
Mr. Zorn holds a Doctor of Pharmacy.
Qiaolin Ren,
Senior Director, Product Development
With over 15 years of pharmaceutical industry experience, Dr. Ren is responsible for portfolio and pipeline development and management.
He has extensive experience in formulation design, process development, technical transfers and manufacturing, and he previously held roles at Novartis, Sandoz, Fougera and Amylin.
Dr. Ren holds a Ph.D. in Industrial Pharmacy.
Lixin Gong,
Senior Director, Analytical Development
With 18 years of pharmaceutical industry experience, Ms. Gong is responsible for analytical development, quality management, and regulatory affairs.
She has in-depth knowledge and experience of analytical method development and validation and a solid understanding of quality systems and GMP/ GLP/FDA/ICH and DEA regulations.
Prior to joining Aucta, she held roles of increasing responsibility with West-Ward, Alpharma, and BMS. Ms. Gong holds a B.S. in Organic Chemistry and an M.S. in Analytical Chemistry.
Bill Mehl,
Director, Quality Assurance
With 30 years of pharmaceutical industry experience, Mr. Mehl is responsible for the company’s quality function.
He has both US and international QA experience building and implanting quality systems and regulatory processes in the pharmaceutical and medical device industries, and his strengths include cGMPs and ISO 13485 for both internal and third party programs. Prior to joining Aucta, Mr. Mehl held roles of increasing responsibility at Bristol-Myers Squibb, Endo Pharmaceuticals, Huahai US, Inc., Nexmed, Inc., and McNeil Specialty Products.
Mr. Mehl holds a B.S. and an M.S. in Biology.